Area of research
Radiology, Nuclear Medicine and Imaging · Otorhinolaryngology
Research interest
Research interests include Head and Neck Cancer Studies, Cancer, Hypoxia, and Metabolism, Medical Imaging Techniques and Applications, and Radiomics and Machine Learning in Medical Imaging.
Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET/CT
Plasma sICAM-1 correlates with tumor volume before primary radiochemotherapy of head and neck squamous cell carcinoma patients
Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
PET/MRI and genetic intrapatient heterogeneity in head and neck cancers
Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy
Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic <sup>18</sup>F-FMISO PET for Head and Neck Cancer Radiotherapy
Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D
Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy
Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy
Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer
Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer
SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
Distortion correction of diffusion-weighted magnetic resonance imaging of the head and neck in radiotherapy position
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
OC-0440: Impact of chemokine receptor CXCR4 and its ligand SDF1 expression on loco-regional control in HNSCC
Robustness of quantitative hypoxia PET image analysis for predicting local tumor control